IL115592A - Stabilized pharmaceutical formulation comprising a growth hormone and leucine - Google Patents

Stabilized pharmaceutical formulation comprising a growth hormone and leucine

Info

Publication number: IL115592A
Authority: IL; Israel
Prior art keywords: growth hormone; leucine; pharmaceutical formulation; stabilized pharmaceutical; dissolved
Prior art date: 1994-10-13

Application number

IL11559295A

Other languages

English (en)

Other versions

IL115592A0 (en

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-13

Filing date

1995-10-12

Publication date

2000-07-26

1995-05-31 Priority claimed from US08/455,886 external-priority patent/US5654278A/en

1995-10-12 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

1996-01-19 Publication of IL115592A0 publication Critical patent/IL115592A0/xx

2000-07-26 Publication of IL115592A publication Critical patent/IL115592A/xx

Links

102000018997 Growth Hormone Human genes 0.000 title abstract 2
108010051696 Growth Hormone Proteins 0.000 title abstract 2
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 title abstract 2
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 title abstract 2
239000000122 growth hormone Substances 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
238000003776 cleavage reaction Methods 0.000 abstract 1
230000006240 deamidation Effects 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
230000003647 oxidation Effects 0.000 abstract 1
238000007254 oxidation reaction Methods 0.000 abstract 1
230000007017 scission Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Endocrinology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Diabetes (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)

IL11559295A 1994-10-13 1995-10-12 Stabilized pharmaceutical formulation comprising a growth hormone and leucine IL115592A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US32283894A	1994-10-13	1994-10-13
US08/455,886 US5654278A (en)	1994-10-13	1995-05-31	Composition and method comprising growth hormone and leucine

Publications (2)

Publication Number	Publication Date
IL115592A0 IL115592A0 (en)	1996-01-19
IL115592A true IL115592A (en)	2000-07-26

Family

ID=26983636

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL11559295A IL115592A (en)	1994-10-13	1995-10-12	Stabilized pharmaceutical formulation comprising a growth hormone and leucine

Country Status (8)

Country	Link
EP (1)	EP0785797B1 (de)
JP (1)	JP4064455B2 (de)
AT (1)	ATE213953T1 (de)
AU (1)	AU699369B2 (de)
DE (1)	DE69525757T2 (de)
ES (1)	ES2172594T3 (de)
IL (1)	IL115592A (de)
WO (1)	WO1996011704A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20070179096A1 (en)	1996-04-24	2007-08-02	Novo Nordisk A/S	Pharmaceutical Formulation
AUPQ387599A0 (en) *	1999-11-05	1999-12-02	Metabolic Pharmaceuticals Limited	Product and method for control of obesity
JP4711520B2 (ja)	2000-03-21	2011-06-29	日本ケミカルリサーチ株式会社	生理活性ペプチド含有粉末
MXPA03001092A (es)	2000-08-07	2003-09-25	Nektar Therapeutics Al Corp	Polvos de proteina de haz de 4 helices secados por rocio, inhalables, que tienen agregacion minimizada.
RS60101B1 (sr) *	2008-08-15	2020-05-29	Ironwood Pharmaceuticals Inc	Formulacije koje sadrže linaklotid za oralnu primenu
RU2012109415A (ru) *	2009-08-13	2013-09-20	Айронвуд Фармасьютикалз, Инк.	Способ модуляции фармакодинамического эффекта перорально вводимых агонистов рецептора гуанилатциклазы
US20140162963A1 (en) *	2010-09-11	2014-06-12	Forest Laboratories Holdings Limited	Treatment of Constipation-Predominant Irritable Bowel Syndrome

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5967228A (ja) *	1982-10-07	1984-04-16	Green Cross Corp:The	寒冷不溶性グロブリンの凍結乾燥方法
EP0303746B2 (de) *	1987-08-21	1998-12-02	Mallinckrodt Group Inc.	Stabilisierung von Wachstumshormonen
DE10399015I1 (de) *	1991-12-20	2012-05-03	Novo Nordisk As	Stabilisierte pharmazeutische formulierung, die wachstumshormon und histidin enthält
SE9201073D0 (sv) *	1992-04-03	1992-04-03	Kabi Pharmacia Ab	Protein formulation

1995
- 1995-10-12 IL IL11559295A patent/IL115592A/xx not_active IP Right Cessation
- 1995-10-13 EP EP95933347A patent/EP0785797B1/de not_active Expired - Lifetime
- 1995-10-13 WO PCT/DK1995/000410 patent/WO1996011704A1/en not_active Ceased
- 1995-10-13 AU AU36054/95A patent/AU699369B2/en not_active Ceased
- 1995-10-13 JP JP51286396A patent/JP4064455B2/ja not_active Expired - Fee Related
- 1995-10-13 AT AT95933347T patent/ATE213953T1/de not_active IP Right Cessation
- 1995-10-13 ES ES95933347T patent/ES2172594T3/es not_active Expired - Lifetime
- 1995-10-13 DE DE69525757T patent/DE69525757T2/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JP4064455B2 (ja)	2008-03-19
DE69525757D1 (de)	2002-04-11
AU3605495A (en)	1996-05-06
AU699369B2 (en)	1998-12-03
ATE213953T1 (de)	2002-03-15
IL115592A0 (en)	1996-01-19
DE69525757T2 (de)	2002-10-17
ES2172594T3 (es)	2002-10-01
EP0785797B1 (de)	2002-03-06
EP0785797A1 (de)	1997-07-30
WO1996011704A1 (en)	1996-04-25
JPH10507183A (ja)	1998-07-14

Similar Documents

Publication	Publication Date	Title
ZA958604B (en)	1996-05-14	A pharmaceutical formulation
IL115591A0 (en)	1996-01-19	Pharmaceutical formulation comprising a growth hormone and valine
HU9401831D0 (en)	1994-09-28	Stabilized pharmaceutical formulations comprising growth hormone and asparagine
CA2125855A1 (en)	1993-07-08	A stabilized pharmaceutical formulation comprising growth hormone and histidine
AU4697396A (en)	1996-07-24	Peptide, peptide analog and amino acid analog protease inibitors
AU2173988A (en)	1989-04-27	Stabilised human protein preparations
CA2149925A1 (fr)	1995-03-30	Derives peptidiques de l'.alpha.-msh et leur application
WO1995013297A3 (en)	1995-06-15	Improved immunogenic compositions against human gastrin 17
CA2156408A1 (en)	1994-09-24	Aerosol formulation containing a polyester dispersing aid
IL137904A0 (en)	2001-10-31	Peptide analogues of insulin and pharmaceutical compositions containing the same
BG106046A (en)	2002-05-31	Pharmaceutical compositions of ertythropoietin
IL115592A0 (en)	1996-01-19	Pharmaceutical formulation comprising a growth hormone and leucine
NZ328402A (en)	1999-03-29	Aprotinin variants having the amino acid arg in position 15 and optionally ala in position 17 and medicaments containing them
MX9800309A (es)	1998-07-31	Formulacion farmaceutica estabilizada que comprende una hormona del crecimiento y un peptido que comprende al menos un residuo de aminoacido basico y al menos un residuo de aminoacido acido.
MX9800358A (es)	1998-07-31	Formulacion farmaceutica estabilizada que comprende una hormona del crecimiento pretratada con zinc y opcionalmente lisina o iones calcio.
AU8375891A (en)	1992-03-19	Antioxidant system based on a basic amino acid in combination with a tocopherol or derivative thereof and a nonthiolated polypeptide, and compositions containing the same
EP0490383A3 (en)	1993-06-30	Peptides of the hiv-gag protein, their preparation and use
GR3022709T3 (en)	1997-05-31	Aerosol composition containing fusafungine.
AU1519399A (en)	1999-05-31	Compositions providing for increased igf-i solubility
WO2002079247A3 (en)	2003-10-30	Intimins in the prevention or treatment of infections:ii
AU1879097A (en)	1997-09-16	Fragments of cr1 and their use
Lees et al.	1993	Retraction concerning the E2 protein of human papillovirus type 16: overexpression and purification of an active transcriptional regulator [Lees, ME, Dreissen, HPC, Crawford, LV & Clarke, AR (1990) Eur. J. Biochem. 190, 85-92.] Expression of the human papillovirus type 16 E2 protein in Escherichia coli
IT1254453B (it)	1995-09-25	Composizioni farmaceutiche per uso orale a base di glutatione ridotto
IT1258818B (it)	1996-02-29	Composizioni farmaceutiche orali a base di n5-metiltetraidrofolato di calcio
IT1241459B (it)	1994-01-17	Composizioni farmaceutiche per la somministrazione rettale di calcitonina

Legal Events

Date	Code	Title
2000-12-06	FF	Patent granted
2002-02-10	KB	Patent renewed
2006-08-01	MM9K	Patent not in force due to non-payment of renewal fees